MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease

M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie (Chicago, USA)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To study the utilization of healthcare and deep brain stimulation (DBS) in large populations of Black and White patients with Parkinson’s disease (PD).

Background: Information on the utilization of healthcare and DBS in Black compared with White patients with PD remains sparse, due to limited number and information available in Black patients in healthcare system.

Method: We searched electronic medical records in Black and White patients with PD in our tertiary center between 1/1/2006 and 10/1/2021, followed by chart reviewing and extracting on demographics, socioeconomic status, comorbidities, and comprehensive healthcare utilization (including DBS) for analysis.

Results: Of 2827 Black and White patients with PD in electronic records, 1211 were assessed by movement neurologists here, who verified the diagnosis in 882 of them (72.8%). We included 846 patients (95.9%) (Black/White 255/591) for analysis. Compared with White patients, Black patients were older at age of onset, lacked male predominance, had lower socioeconomic status, more smokers, more comorbidities, frequent care in emergency and inpatient settings and slightly shorter survival, but no difference in overall medication use to treat motor and major non-motor symptoms. Importantly, Black patients were less likely to have DBS implanted (adjusted odds ratio 0.29 (95% CI 0.14-0.59, p = 0.001), less likely to accept DBS when indicated (p=0.023), and less likely to be evaluated for DBS candidature (p=0.006), but more likely to have supplementary care, compared with White patients.

Conclusion: The new information found in healthcare utilization, particularly in DBS and supplementary care, in Black compared with White patients reveal new insights to improve healthcare.

To cite this abstract in AMA style:

M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie. Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/utilization-of-healthcare-and-deep-brain-stimulation-in-black-and-white-patients-with-parkinsons-disease/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/utilization-of-healthcare-and-deep-brain-stimulation-in-black-and-white-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley